Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:36 pm Purchase | 13G | INMED PHARMACEUTICALS INC INM | ARMISTICE CAPITAL LLC | 696,318 4.990% | 90,104 (+14.86%) | View |
| 2024-11-12 1:44 pm Purchase | 13G | INMED PHARMACEUTICALS INC INM | AdvisorShares Trust | 733,296 8.770% | 733,296 (New Position) | View |
| 2024-02-14 2:28 pm Purchase | 13G | INMED PHARMACEUTICALS INC INM | ARMISTICE CAPITAL LLC | 606,214 9.990% | 440,529 (+265.88%) | View |
| 2024-01-03 5:43 pm Purchase | 13G | INMED PHARMACEUTICALS INC INM | SABBY MANAGEMENT LLC | 524,972 11.000% | 524,972 (New Position) | View |
| 2023-02-14 12:58 pm Purchase | 13G | INMED PHARMACEUTICALS INC INM | ARMISTICE CAPITAL LLC | 165,685 9.990% | 165,685 (New Position) | View |
| 2022-02-04 3:29 pm Purchase | 13G | INMED PHARMACEUTICALS INC INM | Hudson Bay Capital Management LP | 559,944 3.810% | 115,500 (+25.99%) | View |
| 2021-02-09 4:05 pm Purchase | 13G | INMED PHARMACEUTICALS INC INM | Hudson Bay Capital Management LP | 444,444 5.970% | 444,444 (New Position) | View |
| 2021-01-20 11:11 am Unchanged | 13G | INMED PHARMACEUTICALS INC INM | Empery Asset Management LP | 444,444 4.990% | 0 (Unchanged) | View |
| 2020-11-18 10:08 am Purchase | 13G | INMED PHARMACEUTICALS INC INM | Empery Asset Management LP | 444,444 6.350% | 444,444 (New Position) | View |